BEAM
Price
$35.41
Change
+$0.86 (+2.49%)
Updated
Jan 14 closing price
Capitalization
3.59B
47 days until earnings call
Intraday BUY SELL Signals
PRQR
Price
$1.65
Change
+$0.01 (+0.61%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
172.77M
35 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BEAM vs PRQR

Header iconBEAM vs PRQR Comparison
Open Charts BEAM vs PRQRBanner chart's image
Beam Therapeutics
Price$35.41
Change+$0.86 (+2.49%)
Volume$2.34M
Capitalization3.59B
ProQR Therapeutics
Price$1.65
Change+$0.01 (+0.61%)
Volume$5.03K
Capitalization172.77M
BEAM vs PRQR Comparison Chart in %
View a ticker or compare two or three
VS
BEAM vs. PRQR commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and PRQR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (BEAM: $35.41 vs. PRQR: $1.64)
Brand notoriety: BEAM and PRQR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 122% vs. PRQR: 114%
Market capitalization -- BEAM: $3.59B vs. PRQR: $172.77M
BEAM [@Biotechnology] is valued at $3.59B. PRQR’s [@Biotechnology] market capitalization is $172.77M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whilePRQR’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • PRQR’s FA Score: 1 green, 4 red.
According to our system of comparison, BEAM is a better buy in the long-term than PRQR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 5 TA indicator(s) are bullish while PRQR’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 5 bullish, 4 bearish.
  • PRQR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than PRQR.

Price Growth

BEAM (@Biotechnology) experienced а +22.40% price change this week, while PRQR (@Biotechnology) price change was -24.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.47%. For the same industry, the average monthly price growth was +3.44%, and the average quarterly price growth was +44.89%.

Reported Earning Dates

BEAM is expected to report earnings on Mar 03, 2026.

PRQR is expected to report earnings on Feb 19, 2026.

Industries' Descriptions

@Biotechnology (+0.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($3.59B) has a higher market cap than PRQR($173M). BEAM YTD gains are higher at: 27.742 vs. PRQR (-18.812). PRQR has higher annual earnings (EBITDA): -38.15M vs. BEAM (-434.55M). BEAM has more cash in the bank: 1.08B vs. PRQR (107M). PRQR has less debt than BEAM: PRQR (16.5M) vs BEAM (151M). BEAM has higher revenues than PRQR: BEAM (55.7M) vs PRQR (15.5M).
BEAMPRQRBEAM / PRQR
Capitalization3.59B173M2,077%
EBITDA-434.55M-38.15M1,139%
Gain YTD27.742-18.812-147%
P/E RatioN/AN/A-
Revenue55.7M15.5M359%
Total Cash1.08B107M1,005%
Total Debt151M16.5M915%
FUNDAMENTALS RATINGS
BEAM vs PRQR: Fundamental Ratings
BEAM
PRQR
OUTLOOK RATING
1..100
7861
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
24
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9799
PRICE GROWTH RATING
1..100
3889
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRQR's Valuation (24) in the Biotechnology industry is in the same range as BEAM (37) in the null industry. This means that PRQR’s stock grew similarly to BEAM’s over the last 12 months.

PRQR's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as BEAM (100) in the null industry. This means that PRQR’s stock grew similarly to BEAM’s over the last 12 months.

BEAM's SMR Rating (97) in the null industry is in the same range as PRQR (99) in the Biotechnology industry. This means that BEAM’s stock grew similarly to PRQR’s over the last 12 months.

BEAM's Price Growth Rating (38) in the null industry is somewhat better than the same rating for PRQR (89) in the Biotechnology industry. This means that BEAM’s stock grew somewhat faster than PRQR’s over the last 12 months.

BEAM's P/E Growth Rating (100) in the null industry is in the same range as PRQR (100) in the Biotechnology industry. This means that BEAM’s stock grew similarly to PRQR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BEAMPRQR
RSI
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 8 days ago
84%
Declines
ODDS (%)
Bearish Trend 6 days ago
84%
Bearish Trend 2 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signal:
Gain/Loss:
PRQR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MCVSX23.010.17
+0.74%
Victory Integrity Small-Cap Value C
TRSLX5.480.03
+0.55%
Transamerica Small Cap Value R
PMVYX18.77-0.12
-0.64%
Putnam Sustainable Future Y
AFYDX48.26-0.33
-0.68%
American Century Large Cap Equity Y
FDTRX201.87-3.67
-1.79%
Franklin DynaTech R6

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+2.49%
CRSP - BEAM
71%
Closely correlated
+1.26%
RXRX - BEAM
62%
Loosely correlated
+3.41%
NTLA - BEAM
61%
Loosely correlated
+2.39%
PRME - BEAM
59%
Loosely correlated
+3.61%
SYRE - BEAM
57%
Loosely correlated
+5.17%
More

PRQR and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRQR has been loosely correlated with RGNX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if PRQR jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRQR
1D Price
Change %
PRQR100%
-2.38%
RGNX - PRQR
49%
Loosely correlated
-0.20%
BEAM - PRQR
46%
Loosely correlated
+2.55%
RNAC - PRQR
44%
Loosely correlated
+5.36%
ETHZ - PRQR
44%
Loosely correlated
+3.62%
DNLI - PRQR
44%
Loosely correlated
+0.89%
More